In this case happened on October 18th 2011, which a German citizen, Oliver Brüstle, submitted a patent about the processes of production neutral precursor cells that used for treatment of neurological diseases that made from human embryonic stem cells. As the request of Greenpeace, the federal tribunal of patent as “Bundespatentgerichf”, ruled that Mr. Brüstle patent was revoked, because that claims to neural precursor cells derived from human embryonic stem cells contravened the morality provisions of German patent law.
Brüstle appealed to the German Federal Court of Justice in 2009, which took the view on the concept of “embryo” in the national legislation. Regarding, that court sought a preliminary ruling from the Court of Justice related
Brüstle appealed to the German Federal Court of Justice in 2009, which took the view on the concept of “embryo” in the national legislation. Regarding, that court sought a preliminary ruling from the Court of Justice related